A national guideline is available to complement European guidelines for the management of clinical trials during the coronavirus pandemic.
The national guideline is the result of collaboration between the FAMHP, the Clinical Trial College, BAREC (Belgian Association of Research Ethics Committees) and a number of research centres. The guideline commences at the time of publication and supplements the European guidelines.
These new guidelines are intended to assist clinical trial sponsors in the management of clinical trials:
- clinical trials for the prevention or treatment of COVID-19;
- ongoing clinical trials in Belgium;
The national guideline will be regularly updated in line with the evolution of the pandemic.